Q1 2026 earnings call highlights: record $280M revenue, raised 2026 growth to 15–20%, margin risks from memory surcharges—read now.

Total sales growth of 22.6% at CER1 or 17.0% as reported, driven by all three therapeutic areas, with accelerating portfolio momentum outside ...

Polaryx Therapeutics (Nasdaq: PLYX), a clinical-stage biotechnology company focused on developing disease-modifying therapies for rare, pediatric lysosomal storage disorders (LSDs), today announced ...

Corteva Inc. (NYSE: CTVA) announced today the executive leadership team that will lead "SpinCo," the publicly-traded, advanced seed and genetics company resulting from the current company's planned ...

Prediction markets are offering additional insight into expectations. Traders on Polymarket are currently assigning just over ...

AI systems can approve transactions, rebalance portfolios, adjust credit limits, detect fraud, block payments and optimize ...

Gold and silver prices have remained highly volatile, especially after begging of the US-Iran war. However, analysts believe ...

Despite differences between diplomats and military officials, Iranian authorities have largely presented a united front ...

Calix completed the transition to Google Cloud, unlocking expanded platform capabilities and access to new markets.

In Asia’s corporate economy, money no longer simply moves. It flows, adapts and increasingly anticipates. From Shenzhen’s ...

Iran says Israel is violating the ceasefire deal President Trump announced, and Tehran appears to still have control over ...

The Ministry of Science and Technology Vietnam has approved a new funding program aimed at supporting outstanding doctoral ...